Cleared Traditional

K212883 - ers2 - ergoline Rehabilitation System

K212883 is an FDA 510(k) clearance for ers2 - ergoline Rehabilitation System, manufactured by Ergoline GmbH. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 308-day FDA review.

K212883 · Ergoline GmbH · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
308d
Days
Class 2
Risk

K212883 is an FDA 510(k) clearance for the ers2 - ergoline Rehabilitation System. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Ergoline GmbH (Bitz, DE). The FDA issued a Cleared decision on July 15, 2022 after a review of 308 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Ergoline GmbH devices

FDA 510(k) Submission Details - K212883

510(k) Number K212883 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2021
Decision Date July 15, 2022
Days to Decision 308 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
183d slower than avg
Panel avg: 125d · This submission: 308d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 73
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K212883.
Care Team Portal
K222398 · Vivify Health, Inc. · Feb 2023
BioButton System
K212957 · Biolntellisense, Inc. · Dec 2022
ANNE Pediatric
K221530 · Sibel, Inc. · Nov 2022
EZYPRO ECG Recorder (Model: UG02)
K213233 · Sigknow Biomedical Co., Ltd. · Jun 2022
Alio Medical Remote Monitoring System
K211365 · Graftworx, Inc. Dba Alio · Mar 2022
LifePath Remote Patient Monitoring Platform
K211822 · Elastic Care Incorporated · Feb 2022